Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hyuk Woo Lee is active.

Publication


Featured researches published by Hyuk Woo Lee.


Journal of the National Cancer Institute | 2014

Overactivated Neddylation Pathway as a Therapeutic Target in Lung Cancer

Lihui Li; Mingsong Wang; Guangyang Yu; Ping Chen; Hui Li; Dongping Wei; Ji Zhu; Li Xie; Huixun Jia; Jie-Yi Shi; Chunjie Li; Wantong Yao; Yanchun Wang; Qiang Gao; Lak Shin Jeong; Hyuk Woo Lee; Jinha Yu; Fengqing Hu; Ju Mei; Ping Wang; Yiwei Chu; Hui Qi; Meng Yang; Ziming Dong; Yi Sun; Robert M. Hoffman; Lijun Jia

BACKGROUND A number of oncoproteins and tumor suppressors are known to be neddylated, but whether the neddylation pathway is entirely activated in human cancer remains unexplored. METHODS NEDD8-activating enzyme (NAE) (E1) and NEDD8-conjugating enzyme (E2) expression and global-protein neddylation were examined by immunohistochemistry, immunoblotting, and real-time polymerase chain reaction analysis. Cell proliferation, clonogenic survival, migration, and motility in vitro, as well as tumor formation and metastasis in vivo, were determined upon neddylation inhibition by MLN4924, an investigational NEDD8-activating enzyme inhibitor. Survival was analyzed with Kaplan-Meier methods and compared by the log-rank test. All statistical tests were two-sided. RESULTS The entire neddylation pathway, including NEDD8-activating enzyme E1, NEDD8-conjugating enzyme E2, and global-protein neddylation, is overactivated in both lung adenocarcinoma and squamous-cell carcinoma. Compared with lung adenocarcinoma patients with low expression, those with high expression had worse overall survival (NEDD8-activating enzyme E1 subunit 1 [NAE1]: hazard ratio [HR] = 2.07, 95% confidence interval [CI] = 0.95 to 4.52, P = .07; ubiquitin-conjugating enzyme E2M (UBC12): HR = 13.26, 95% CI = 1.77 to 99.35, P = .01; global protein neddylation: HR = 3.74, 95% CI = 1.65 to 8.47, P = .002). Moreover, inhibition of neddylation by the NAE inhibitor MLN4924 statistically significantly suppressed proliferation, survival, migration, and motility of lung cancer cells in vitro and tumor formation and metastasis in vivo. At the molecular level, MLN4924 inactivated Cullin-RING E3 ligases, led to accumulation of tumor-suppressive Cullin-RING E3 ligase substrates and induced phorbol-12-myristate-13-acetate-induced protein 1 (NOXA)-dependent apoptosis or cellular senescence. CONCLUSIONS Our study highlights the overactivated neddylation pathway in lung cancer development and as a promising therapeutic target.


Applied Physics Letters | 1993

Experimental study of volume holographic interconnects using random patterns

Hyuk Woo Lee; Sang Kyu Jin

An optical interconnecting scheme utilizing volume holograms of random patterns instead of plane waves is described. The new method is analyzed by using a perturbative integral expansion technique. Experimental results demonstrating the new scheme are also presented.


Molecular Cancer Therapeutics | 2006

The antitumor effect of LJ-529, a novel agonist to A3 adenosine receptor, in both estrogen receptor–positive and estrogen receptor–negative human breast cancers

Heekyoung Chung; Ji-Youn Jung; Sung-Dae Cho; Kyung-A Hong; Hyun-Jun Kim; Dong-Hui Shin; Hwan Kim; Hea Ok Kim; Dae Hong Shin; Hyuk Woo Lee; Lak Shin Jeong; Gu Kong

Agonists to A3 adenosine receptor (A3AR) have been reported to inhibit cell growth and/or induce apoptosis in various tumors. We tested the effect of a novel A3AR agonist generically known as LJ-529 in breast cancer cells. Anchorage-dependent cell growth and in vivo tumor growth were attenuated by LJ-529, independently of its estrogen receptor (ER) α status. In addition, apoptosis was induced as evidenced by the activation of caspase-3 and c–poly(ADP)ribose polymerase. Furthermore, the Wnt signaling pathway was down-regulated and p27kip was induced by LJ-529. In ER-positive cells, the expression of ER was down-regulated by LJ-529, which might have additionally contributed to attenuated cell proliferation. In ER-negative, c-ErbB2-overexpressing SK-BR-3 cells, the expression of c-ErbB2 and its downstream extracellular signal-regulated kinase pathway were down-regulated by LJ-529. However, such effect of LJ-529 acted independently of its receptor because no A3AR was detected by reverse transcription-PCR in all four cell lines tested. In conclusion, our novel findings open the possibility of LJ-529 as an effective therapeutic agent against both ER-positive and ER-negative breast cancers, particularly against the more aggressive ER-negative, c-ErbB2-overexpressing types. [Mol Cancer Ther 2006;5(3):685–92]


American Journal of Pathology | 2013

The Selective A3AR Antagonist LJ-1888 Ameliorates UUO-Induced Tubulointerstitial Fibrosis

Ji-Youn Lee; Inah Hwang; Jung H. Lee; Hyuk Woo Lee; Lak-Shin Jeong; Hunjoo Ha

Adenosine in the normal kidney significantly elevates in response to cellular damage. The renal A3 adenosine receptor (A3AR) is up-regulated under stress, but the therapeutic effects of A3AR antagonists on chronic kidney disease are not fully understood. The present study examined the effect of LJ-1888 [(2R,3R,4S)-2-[2-chloro-6-(3-iodobenzylamino)-9H-purine-9-yl]-tetrahydrothiophene-3,4-diol], a newly developed potent, selective, species-independent, and orally active A3AR antagonist, on unilateral ureteral obstruction (UUO)-induced renal fibrosis. Pretreatment with LJ-1888 inhibited UUO-induced fibronectin and collagen I up-regulation in a dose-dependent manner. Massons trichrome staining confirmed that LJ-1888 treatment effectively reduced UUO-induced interstitial collagen accumulation. Furthermore, delayed administration of LJ-1888 showed an equivalent therapeutic effect on tubulointerstitial fibrosis to that of losartan. Small-interfering A3AR transfection effectively inhibited transforming growth factor-β1 (TGF-β1)-induced fibronectin and collagen I up-regulation in proximal tubular cells similar to LJ-1888, confirming that the renoprotective effect of LJ-1888 resulted from A3AR blockade. UUO- or TGF-β1-induced c-Jun N-terminal kinase and extracellular signal-regulated kinase phosphorylation decreased significantly after LJ-1888 administration. A3AR blockade reduced UUO- or TGF-β1-induced up-regulation of lysyl oxidase, which induces cross-linking of extracellular matrix, suggesting that LJ-1888 may also regulate extracellular matrix accumulation via post-translational regulation. In conclusion, the present data demonstrate that the A3AR antagonist, LJ-1888, blocked the development and attenuated the progression of renal fibrosis, and they suggest that LJ-1888 may become a new therapeutic modality for renal interstitial fibrosis.


Journal of Organic Chemistry | 2011

Stereoselective Synthesis of MLN4924, an Inhibitor of NEDD8-Activating Enzyme

Hyuk Woo Lee; Soo Kyung Nam; Won Jun Choi; Hea Ok Kim; Lak Shin Jeong

MLN4924 (1), which is in clinical trials as an anticancer agent, was stereoselectively synthesized from d-ribose via a route involving stereoselective reduction, regioselective cleavage of an isopropylidene moiety, and selective displacement of a cyclic sulfate moiety as key steps.


Biochemical and Biophysical Research Communications | 2013

Neddylation pathway regulates the proliferation and survival of macrophages

Lihui Li; Binghong Liu; Tiangeng Dong; Hyuk Woo Lee; Jinha Yu; Yijie Zheng; Haifeng Gao; Yan Zhang; Yiwei Chu; Guangwei Liu; Weixin Niu; Shimin Zheng; Lak Shin Jeong; Lijun Jia

Neddylation is a new type of protein post-translational modification which adds the ubiquitin-like molecule Nedd8 to target proteins. The well-identified targets of neddylation are cullins, which serve as essential components of Cullin-RING E3 ligases (CRL). It is reported that inhibition of neddylation repressed NF-κB-mediated proinflammatory cytokine production in macrophages. However, the role of neddylation in the proliferation and survival of macrophages has not been well defined. Here we report that partial inactivation of the neddylation pathway by a specific Nedd8-activating enzyme E1 (NAE) inhibitor MLN4924 reduced LPS-induced production of the proinflammatory cytokines TNF-α and IL-6 without obvious impairment of cell viability. However, persistent and severe inactivation of neddylation by MLN4924 significantly inhibited cell proliferation by inducing G2 phase cell-cycle arrest and further triggered cell death by inducing apoptosis in RAW264.7 macrophages. Mechanistic analysis revealed that inactivation of neddylation blocked cullin neddylation, inhibited CRL E3 ligase activity, and thus led to the accumulation of CRL substrates, resulting in cell-cycle arrest, DNA damage response and apoptosis. The findings revealed that neddylation serves as an important signaling pathway regulating the proliferation and survival of macrophages.


Ultrasonics | 2015

Multiple beam splitting in elastic phononic crystal plates

Hyuk Woo Lee; Joo Hwan Oh; Yoon Young Kim

This work presents an experimental evidence for triple beam splitting in an elastic plate with an embedded elastic phononic crystal (PC) prism and elaborates on its working mechanism. While there were reports on negative refraction and double beam splitting with PCs, no experimental evidence on the splitting of triple or more ultrasonic elastic beams through PCs has been shown yet. After the experimental results are presented in case of triple beam splitting, further analysis is carried out to explain how triple or more beams can be split depending on elastic PC prism angles.


Bioorganic & Medicinal Chemistry Letters | 2011

Discovery of new inhibitor for PDE3 by virtual screening.

Ki Young Kim; Hyuk Woo Lee; Sung-Eun Yoo; Seong Hwan Kim; Nam Sook Kang

In this work, we tried to find a new scaffold for a PDE3 using virtual screening for the obesity treatment. We first analyzed structural features for the known PDE3 inhibitors based on the PDE3B-ligand complex structure, and then carried out a docking study based on PDE3B 3D structure. We obtained a compound as potent PDE3 inhibitor stimulating lipolysis in murine adipocytes and human adipocytes.


international conference on computer communications | 2015

ChASER: Channel-aware symbol error reduction for high-performance WiFi systems in dynamic channel environment

Okhwan Lee; Weiping Sun; Jihoon Kim; Hyuk Woo Lee; Bo Ryu; Jungwoo Lee; Sunghyun Choi

Due to considerable increases in user mobility and frame length through aggregation, the wireless channel remains no longer time-invariant during the (aggregated) frame transmission time. However, the existing IEEE 802.11 standards still define the channel estimation to be performed only once at the preamble for coherent OFDM receivers, and the same channel information to be used throughout the entire (aggregated) frame processing. Our experimental results reveal that this baseline channel estimation approach seriously deteriorates the WiFi performance, especially for pedestrian mobile users and the recently adopted frame aggregation scheme. In this paper, we propose Channel-Aware Symbol Error Reduction (ChASER), a new practical channel estimation and tracking scheme for WiFi receivers. ChASER utilizes the re-encoding and re-modulation of the received data symbol to keep up with the wireless channel dynamics at the granularity of OFDM symbols. Our extensive, trace-driven link-level simulation shows significant performance gains over a wide range of channel conditions based on the real wireless channel traces collected by the off-the-shelf WiFi device. In addition, the feasibility of its low-complexity and standard compliance is demonstrated by Microsofts Software Radio (Sora) prototype implementation and experimentation. To our knowledge, ChASER is the first IEEE 802.11n-compatible channel tracking algorithm since other approaches addressing the time-varying channel conditions over a single (aggregated) frame duration require costly modifications of the IEEE 802.11n standard.


Archives of Pharmacal Research | 2007

Alternative and improved syntheses of highly potent and selective A3 adenosine receptor agonists, CI-IB-MECA and Thio-CI-IB-MECA

Xiyan Hou; Hyuk Woo Lee; Dilip K. Tosh; Long Xuan Zhao; Lak Shin Jeong

Improved syntheses of potent and selective A3 adenosine receptor agonists, CI-IB-MECA and thio-CI-IB-MECA were accomplished from cheap stating material, D-ribose. New synthetic methods were found to be superior to old methods from the viewpoint of use of cheap starting material, number of steps, and overall yields.

Collaboration


Dive into the Hyuk Woo Lee's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kenneth A. Jacobson

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Hea Ok Kim

Ewha Womans University

View shared research outputs
Top Co-Authors

Avatar

Hea Ok Kim

Ewha Womans University

View shared research outputs
Top Co-Authors

Avatar

Zhan-Guo Gao

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dilip K. Tosh

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge